Olfaction in patients with suspected parkinsonism and scans without evidence of dopaminergic deficit (SWEDDs)

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Neurology Neurosurgery & Psychiatry

• Publication date

  2009-03-09

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/jnnp.2009.172825PMID 19276101
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Parkinson's disease].

  2022cited by this paper
• The use of a color coded probability scale to interpret smell tests in suspected parkinsonism

  2009cited by this paper
• Role of DAT‐SPECT in diagnostic work‐up of Parkinsonism

  2008cited by this paper
• [123I]-FP-CIT SPECT and olfaction test in patients with combined postural and rest tremor

  2008cited by this paper
• Olfactory tests in the diagnosis of essential tremor.

  2008cited by this paper
• Adult onset dystonia can cause tremulous pseudoparkinsoniasm and is one cause of SWEDDs: Clinical description of 30 cases

  2008cited by this paper
• Reply: Role of DAT SPECT in the diagnostic work‐up of Parkinsonism

  2008cited by this paper
• Consensus Statement of the Movement Disorder Society on Tremor

  2008cited by this paper
• Olfaction is normal in essential tremor and can be used to distinguish it from parkinson disease

  2007influential reference
• Patients with adult‐onset dystonic tremor resembling parkinsonian tremor have scans without evidence of dopaminergic deficit (SWEDDs)

  2007influential reference
• Olfactory Dysfunction in Parkinson’s Disease

  2007cited by this paper
• Two-year follow-up in 150 consecutive cases with normal dopamine transporter imaging

  2006cited by this paper
• Successful antiparkinsonian medication withdrawal in patients with Parkinsonism and normal FP‐CIT SPECT

  2006influential reference
• Essential tremor: mild olfactory dysfunction in a cerebellar disorder.

  2005cited by this paper
• (123I) β-CIT and Single-Photon Emission Computed Tomographic Imaging vs Clinical Evaluation in Parkinsonian Syndrome: Unmasking an Early Diagnosis

  2004cited by this paper
• Levodopa and the progression of Parkinson's disease.

  2004cited by this paper
• Impact of dopamine transporter SPECT using 123I‐Ioflupane on diagnosis and management of patients with clinically uncertain parkinsonian syndromes

  2004cited by this paper
• Olfactory function in essential tremor: a deficit unrelated to disease duration or severity.

  2003cited by this paper
• Prospective study of presynaptic dopaminergic imaging in patients with mild parkinsonism and tremor disorders: Part 1. Baseline and 3‐month observations

  2003cited by this paper
• Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL‐PET study

  2003cited by this paper
• Dopamine transporter imaging and SPECT in diagnostic work‐up of Parkinson's disease: A decision‐analytic approach

  2003cited by this paper
• Brain parenchyma sonography discriminates Parkinson's disease and atypical parkinsonian syndromes. Authors' reply

  2003cited by this paper
• Olfactory dysfunction in essential tremor

  2002cited by this paper
• The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service.

  2002cited by this paper
• Olfactory function in Parkinsonian syndromes.

  2002cited by this paper
• Prevalence of olfactory impairment in older adults.

  2002cited by this paper
• Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group.

  2000cited by this paper
• Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-up.

  2000cited by this paper
• Prevalence of Parkinson's disease in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group.

  2000cited by this paper
• Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]‐FP‐CIT SPECT imaging: The [123I]‐FP‐CIT study group

  2000cited by this paper
• Fluctuating olfactory sensitivity and distorted odor perception in allergic rhinitis.

  1999cited by this paper
• The role of spectroscopy in parkinsonism

  1998cited by this paper
• Olfactory dysfunction in Parkinson's disease.

  1997cited by this paper
• Fortnightly Review: Parkinsonism—recognition and differential diagnosis

  1995cited by this paper
• Olfactory testing as an aid in the diagnosis of Parkinson's disease: development of optimal discrimination criteria.

  1995cited by this paper
• Olfactory function in essential tremor

  1992cited by this paper
• The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.

  1988cited by this paper
• Recent Developments in Parkinson's Disease

  1986cited by this paper
• Development of the University of Pennsylvania Smell Identification Test: a standardized microencapsulated test of olfactory function.

  1984cited by this paper
• “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician

  1975cited by this paper

• The Utility of Olfactory Testing to Discriminate Parkinson's Disease From Diagnostic Mimics: A Systematic Review and Meta‐Analysis

  2025cites this paper
• Long-term follow-up study of SWEDD patients with mild parkinsonian signs

  2024cites this paper
• Olfactory dysfunction as a diagnostic and prognostic marker for movement disorders

  2024cites this paper
• Sensory processing in the auditory and olfactory domains is normal in laryngeal dystonia

  2023cites this paper
• Patients with scans without evidence of dopaminergic deficit (SWEDD) do not have early Parkinson’s disease: Analysis of the PPMI data

  2021cites this paper
• Parkinsonism

  2021cites this paper
• Olfaction as a Marker for Dystonia: Background, Current State and Directions

  2020cites this paper
• Auditory and Olfactory Deficits in Essential Tremor – Review of the Current Evidence

  2020cites this paper
• Local white matter fiber clustering differentiates Parkinson's disease diagnoses.

  2020cites this paper
• Smell and taste in cervical dystonia

  2020cites this paper
• Chemosensory dysfunction in neurodegenerative diseases.

  2019cites this paper
• Sniffing out cognitive decline in patients with and without evidence of dopaminergic deficit

  2019cites this paper
• PET and SPECT in the assessment of monoaminergic brain systems in extrapyramidal disorders

  2019cites this paper
• Позитронная эмиссионная и однофотонная эмиссионная компьютерная томография в оценке состояния моноаминергических систем мозга при экстрапирамидных расстройствах

  2019cites this paper
• Sekundäre Parkinson-Syndrome

  2018influential citation
• Frontotemporal Lobe Degeneration as Origin of Scans Without Evidence of Dopaminergic Deficit

  2018cites this paper
• Neuropsychological Test Performance in Parkinsonism Without Dopaminergic Deficiency on [123I]-FP-CIT SPECT Imaging

  2018cites this paper
• Neurodegenerative Chemosensory Disorders

  2018cites this paper
• Among Early Appearing Non-Motor Signs of Parkinson’s Disease, Alteration of Olfaction but Not Electroencephalographic Spectrum Correlates with Motor Function

  2017cites this paper
• Molecular Imaging and Precision Medicine in Dementia and Movement Disorders.

  2017cites this paper
• 123I-Meta-iodobenzylguanidine (MIBG) myocardial scintigraphy in patients showing scans without evidence of dopaminergic deficits (SWEDDs).

  2017cites this paper
• Quantitative Electroencephalography and genetics as biomarkers of dementia in Parkinson’s disease

  2017cites this paper
• Nonmotor Symptoms in Essential Tremor and Other Tremor Disorders.

  2017cites this paper
• Non-motor symptoms in patients with uncertain Parkinsonism and Scans Without Evidence of Dopaminergic Deficit (SWEDDs)

  2016cites this paper
• Parkinson’s Disease and Aging

  2016cites this paper
• The role of biomarkers and imaging in Parkinson’s disease

  2016cites this paper
• Molecular imaging of dopamine transporters.

  2016cites this paper
• Progression of nonmotor symptoms in subgroups of patients with non–dopamine‐deficient Parkinsonism

  2016influential citation
• Classification of Scans Without Evidence of Dopamine Deficit (SWEDD) According to the Olfactory Function

  2016cites this paper
• The role of biomarkers and imaging in Parkinson’s disease

  2016cites this paper
• Parkinsonism and Related Disorders

  2016cites this paper
• 24-Hour Ambulatory Blood Pressure Monitoring in SWEDDs Patients With Parkinsonism

  2016cites this paper
• Hyposmia in SWEDD

  2015cites this paper
• Nonmotor Symptoms in Subjects Without Evidence of Dopaminergic Deficits

  2015cites this paper
• Computer-Aided Diagnosis of Parkinson’s Disease Using Enhanced Probabilistic Neural Network

  2015cites this paper
• What do patients with scans without evidence of dopaminergic deficit (SWEDD) have? New evidence and continuing controversies

  2015cites this paper
• Transcranial sonography of the substantia nigra and its correlation with DAT-SPECT in the diagnosis of Parkinson's disease.

  2015cites this paper
• Reply: Nonmotor symptoms in subjects without evidence of dopaminergic deficits

  2015cites this paper
• Patterns of Motor and Non-Motor Features in Medication-Naïve Parkinsonism

  2015cites this paper
• Odor Perception and Neuropathology in Neurodegenerative Diseases and Schizophrenia

  2015cites this paper
• Olfactory bulb involvement in neurodegenerative diseases

  2014cites this paper
• Screening for dopa-responsive dystonia in patients with scans without evidence of dopaminergic deficiency (SWEDD)

  2014cites this paper
• Patients with scans without evidence of dopaminergic deficit: A long‐term follow‐up study

  2014cites this paper
• Sekundäre Parkinson-Syndrome

  2014cites this paper
• Comparison of sleep and other non-motor symptoms between SWEDDs patients and de novo Parkinson's disease patients.

  2014cites this paper
• Prodromale Marker der Parkinson-Krankheit

  2013cites this paper
• Olfactory loss as a supporting feature in the diagnosis of Parkinson’s disease: a pragmatic approach

  2013cites this paper
• Biomarkers for trials of neuroprotection in Parkinson's disease

  2013cites this paper
• Cardiac sympathetic denervation in Parkinson’s disease patients with SWEDDs

  2013cites this paper
• Dopamine: PET Imaging and Parkinson Disease.

  2013cites this paper
• Hyposmia and Cognitive Impairment in Gaucher Disease Patients and Carriers

  2012cites this paper
• Olfactory impairment in familial ataxias

  2012cites this paper
• Neuropathology of sporadic Parkinson's disease: Evaluation and changes of concepts

  2012cites this paper
• Is Transcranial Sonography Useful to Distinguish Scans Without Evidence of Dopaminergic Deficit Patients From Parkinson's Disease?

  2012cites this paper
• Epidemiology, diagnosis and differential diagnosis in Parkinson's disease tremor.

  2012cites this paper
• Dopamine transporter imaging in clinically unclear cases of parkinsonism and the importance of scans without evidence of dopaminergic deficit (SWEDDs).

  2012cites this paper
• Neuroimaging in the early diagnosis of neurodegenerative disease

  2012cites this paper
• Accuracy of subjective and objective handwriting assessment for differentiating Parkinson’s disease from tremulous subjects without evidence of dopaminergic deficits (SWEDDs): an FP-CIT-validated study

  2012cites this paper
• Identifying prodromal Parkinson's disease: Pre‐Motor disorders in Parkinson's disease

  2012cites this paper
• Adapting the Sniffin' Sticks olfactory test to diagnose Parkinson's disease in Estonia.

  2012cites this paper
• Essential tremor: beyond the motor features.

  2012influential citation
• Dopaminergic and behavioral correlates of progressive lesioning of the nigrostriatal pathway with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

  2011cites this paper
• Tardive dyskinesia and other movement disorders secondary to aripiprazole

  2011cites this paper
• Neuroimaging in Parkinson’s Disease

  2011cites this paper
• Silent saliva aspiration in Parkinson's disease

  2011cites this paper
• Apomorphine effect on pain threshold in Parkinson's disease: A clinical and positron emission tomography study

  2011cites this paper
• Use of smell test identification in Parkinson's disease in Mexico: A matched case‐control study

  2011cites this paper
• Clinical and biochemical characterization of patients with early infantile onset of autosomal recessive GTP cyclohydrolase I deficiency without hyperphenylalaninemia

  2011cites this paper
• Gait in SWEDDs patients: Comparison with Parkinson's disease patients and healthy controls

  2011influential citation
• Parkinsonism: heterogeneity of a common neurological syndrome.

  2011cites this paper
• Essential tremor and Parkinson's disease: Lack of a link

  2011cites this paper
• Premotor Symptoms and Early Diagnosis of Parkinson's Disease

  2011cites this paper
• Serum urate and probability of dopaminergic deficit in early “Parkinson's disease”

  2011cites this paper
• EFECTO DE LA ADMINISTRACIÓN CRÓNICA DE LEVODOPA SOBRE LA ACTIVIDAD FUNCIONAL DE LA VÍA NIGROESTRIADA EN MACACOS CON PARKINSONISMO INDUCIDO POR MPTP

  2010cites this paper
• Biomarkers: Parkinson disease with dementia and dementia with Lewy bodies.

  2010cites this paper
• Imaging dopamine transporters in Parkinson's disease.

  2010cites this paper
• Scans without evidence of dopamine deficiency: The triumph of careful clinical assessment

  2010cites this paper
• A basic smell test is as sensitive as a dopamine transporter scan: comparison of olfaction, taste and DaTSCAN in the diagnosis of Parkinson's disease.

  2010influential citation
• Olfaction as a biomarker in Parkinson's disease.

  2010cites this paper
• Distinguishing SWEDDs patients with asymmetric resting tremor from Parkinson's disease: A clinical and electrophysiological study

  2010cites this paper
• Olfactory dysfunction as a diagnostic marker for Parkinson’s disease

  2009cites this paper
• Chapter 4 – Parkinsonism: Clinical Features and Differential Diagnosis

  2007cites this paper